2.5mgCancer

Fempro

FEMPRO

Letrozole

MASS PHARMA (PRIVATE) LIMITED

Drug Identity

Active Ingredient
Letrozole
Drug Class
Cancer
ATC Code
L02BG04
Status
Essential Medicine

How to Take It

Dosage information not available for this product.

Safety Alerts

Pre-menopausal women, very severe hepatic impairment

Important Warnings

Very severe renal impairment
Susceptibility to osteoporosis

Side Effects

Alopeciaanorexiaappetite increasearthralgiabone fractureconstipationdepressiondiarrhoeadizzinessdry skindyspepsiafatigueheadachehot flusheshypercholesterolaemia

Pregnancy & Lactation

Pregnancy
Positive evidence of risk: Avoid
Lactation
Contraindicated. Discontinue breast-feeding

Price Intelligence

Rs 2,000
Servaid observed price · as of 30 July 2026
No approved ceiling matched to this exact pack and strength.
Prices across sources
ServaidRs 2,000

Should you consider an alternative?

Other options containing Letrozole, and what they are not.You pay Rs 975 more than the cheapest equivalent

For pharma professionalsCompany, market and opportunity intelligence

Company

331
brands
312
molecules
2
alerts

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.